menu search

National youth prevention summit highlights colorado campaign to protect teens from fentanyl

Denver, Colorado, Nov. 02, 2023 (GLOBE NEWSWIRE) — A national youth prevention summit organized by the National High Intensity Drug Trafficking Area...

November 3, 2023, 2:32 am

Ascendis pharma presents results from long-term enlighten trial of transcon™ hgh in pediatric growth hormone deficiency

– The majority of children and adolescents treated once weekly with TransCon hGH (lonapegsomatropin) ...

September 23, 2023, 11:00 am

Pfizer's (pfe) alopecia areata drug litfulo receives eu nod

Pfizer (PFE) gets marketing authorization in the EU for Litfulo to treat adults and adolescent patients...

September 19, 2023, 11:18 am

Gsk's hiv-prevention drug apretude approved by european commission

The European Commission (EC) has authorised GSK PLC (LSE:GSK, NYSE:GSK) subsidiary ViiV Healthcare's HIV-prevention drug Apretude. Known scientificall...

September 19, 2023, 7:19 am

Gold-i launches platform for multi-asset liquidity & distribution

The three combined products: Matrix2 – liquidity management platform Crypto Switch™ – institutional digital asset solution MatrixNET – liquidi...

September 7, 2023, 10:00 am

Pfizer, valneva announce 'positive' results for lyme disease vaccine candidate booster shot

Pfizer and French pharmaceutical peer Valneva announced on Thursday that a phase 2 study for its VLA15 Lyme disease vaccine candidate showed a "strong...

September 7, 2023, 1:22 am

Bristol myers' (bmy) opdivo gets ec nod for label expansion

Bristol Myers (BMY) obtains approval in the EU for Opdivo for the adjuvant treatment of adults and adoles...

August 23, 2023, 12:47 pm

Kion group ag (kigry) q2 2023 earnings call transcript

KION GROUP AG (OTCPK:KIGRY) Q2 2023 Earnings Conference Call July 27, 2023 9:00 AM ET Company Participants Rob Smith - CEO Christian Harm - CFO Confer...

July 30, 2023, 10:39 am

Games workshop doles out cash as sales hit 29 year record

Games Workshop upped its annual dividend by more than 76% as it confirmed last year had seen the highest sales since it floated 29 years ago. Revenues...

July 25, 2023, 3:26 am

Medtech company neuraxis upsizes ipo and lowers price to $6 a share vs. $8 previously

NeurAxis, a medical technology company with an FDA-approved therapy to treat abdominal pain associated with IBS in a...

July 21, 2023, 6:20 am

Uk seafood fund doles out gbp 21 million in grants

It is the latest payout from the GPB 100 million (USD 121 million, EUR 119 million) U.K. Seafood Fund, which was established to support the long-term ...

July 19, 2023, 10:44 am

The great market miscalculation: pfizer's true value remains untapped

Ngenla, a long-acting medicine for treating children with growth hormone deficiency, has been approved by the FDA for use in the United States, adding...

June 30, 2023, 9:15 am

Pfizer's (pfe) litfulo receives fda nod for alopecia areata

Pfizer's (PFE) Litfulo becomes the first kinase inhibitor approved for treating severe alopecia areata in adol...

June 26, 2023, 9:46 am

Novo nordisk (nvo) growth hormone drug gets positive chmp opinion

Novo Nordisk (NVO) gets CHMP recommendation approval for Sogroya for expanded use in children and adoles...

May 26, 2023, 1:35 pm

U.s. surgeon general warns that social media poses a ‘profound risk of harm' for children

Social media platforms pose “a profound risk of harm to the mental health and well-being of children,” and there is not enough “evidence to dete...

May 23, 2023, 4:28 pm

Incyte (incy) opzelura gets ec nod for non-segmental vitiligo

Incyte (INCY) gets EC approval for Opzelura (cream formulation of ruxolitinib) for the treatment of non-segmental vitiligo with facial involvement in ...

April 21, 2023, 2:26 pm

Tonix pharmaceuticals exec presents data on prader-willi syndrome drug at rare disease conference

Tonix Pharmaceuticals (NASDAQ:TNXP) Holding Corp EVP of translation medicine Herbert Harris delivered an oral presentation Thursday at the Rare Diseas...

March 23, 2023, 4:41 pm

Dupixent® (dupilumab) application for treatment of chronic spontaneous urticaria (csu) in adults and adolescents aged 12 years and older accepted for fda review

More than 300,000 people in the U.S. suffer from CSU that is inadequately controlled by antihistamines TARRYTOWN, N.Y. and PARIS, March 07, 2023 (GLOB...

March 7, 2023, 6:00 am

Reata pharmaceuticals wins key fda approval for rare disease treatment friedreich's ataxia, sending shares soaring

Biopharma company Reata Pharmaceuticals Inc (NASDAQ:RETA) was in the spotlight on Wednesday after a key approval from the US Food and Drug Administra...

March 1, 2023, 12:23 pm

Cryptoverse: bitcoin moves towards satoshi’s payment dream

Adolescent bitcoin may finally be repaying its creator’s faith.The 15-year-old cryptocurrency has fil...

February 28, 2023, 6:29 am


Search within

Pages Search Results: